Kenneth Code
Vermögen: 3 Mio $ am 31.05.2026
Vermögen: 3 Mio $ am 31.05.2026
Kenneth Reay Code is the founder of IOWC Technologies, Inc. Mr. Code currently holds the positions of Director & Chief Science Officer at BioLargo, Inc. since 2007 and Chief Science Officer at BioLargo Life Technologies, Inc. since 2011.
Mr. Code completed undergraduate education at the University of Calgary.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOLARGO, INC. 8.06% | 30.04.2026 | 25’875’752 ( 8.06% ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOLARGO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2007 |
BioLargo Life Technologies, Inc.
BioLargo Life Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the physical, engineering and life sciences | Technik-/Wissenschafts-/F&E-Leiter | - |
| Unternehmen | Position | Ende |
|---|---|---|
IOWC Technologies, Inc.
IOWC Technologies, Inc. Metal FabricationProducer Manufacturing Manufactures technologies used to disinfect absorbent materieals | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
BioLargo, Inc.
BioLargo, Inc. Chemicals: SpecialtyProcess Industries Provides technology solutions for odor and moisture control, disinfection and contaminated water treatment | Process Industries |
IOWC Technologies, Inc.
IOWC Technologies, Inc. Metal FabricationProducer Manufacturing Manufactures technologies used to disinfect absorbent materieals | Producer Manufacturing |
University of Calgary
University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLargo Life Technologies, Inc.
BioLargo Life Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the physical, engineering and life sciences | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen